
Hurler Syndrome - Cleveland Clinic
Aug 17, 2022 · Hurler syndrome is the most severe form of mucopolysaccharidosis type I, a hereditary lysosomal storage condition. Cells can't break down sugar molecules, which affects how they function. Symptoms are life-threatening, target your bones and organs, and could cause issues with cognitive development. Treatment increases life expectancy.
Mucopolysaccharidosis type I - Wikipedia
Mucopolysaccharidosis type I is a spectrum of diseases in the mucopolysaccharidosis family. It results in the buildup of glycosaminoglycans (or GAGs, or mucopolysaccharides) due to a deficiency of alpha-L iduronidase, an enzyme responsible for …
Mucopolysaccharidosis Type I - GeneReviews® - NCBI Bookshelf
Oct 31, 2002 · Mucopolysaccharidosis type I (MPS I) is a progressive multisystem disorder with features ranging over a continuum of severity.
Mucopolysaccharidosis type I - MedlinePlus
Mucopolysaccharidosis type I (MPS I) is a condition that affects many parts of the body. This disorder was once divided into three separate syndromes: Hurler syndrome (MPS I-H), Hurler-Scheie syndrome (MPS I-H/S), and Scheie syndrome (MPS I-S), listed from most to least severe.
Mucopolysaccharidosis Type I - Symptoms, Causes, Treatment
Apr 22, 2019 · Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that affects many parts of the body (multisystem). Children with MPS I are described as having either a severe or attenuated (meaning reduced) form of the disorder based on age of onset, severity of symptoms, rate of disease progression and whether there is early and direct ...
Mucopolysaccharidosis Type 1 (MPS 1) - Children's Hospital of Philadelphia
What is mucopolysaccharidosis type 1? Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disorder characterized by an abnormal build-up of various toxic materials, called glycosaminoglycans (GAGs) in the body's cells.
Mucopolysaccharidosis I (MPS I) - Hurler Syndrome and Scheie ... - WebMD
Sep 4, 2023 · Mucopolysaccharidosis I (MPS I) is a rare genetic disorder that affects both physical and mental development and can cause organ damage.
Mucopolysaccharidosis Type I: Current Treatments, Limitations, …
Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). Currently approved treatments consist of enzyme replacement therapy (ERT) and/or hematopoietic stem cell transplantation (HSCT).
MPS I (Hurler Syndrome) - Boston Children's Hospital
What is MPS I (Hurler syndrome)? Mucopolysarcharidosis type I (MPS I) is a rare, inherited disorder. MPS I is also known as Hurler syndrome. Children with Hurler syndrome have an abnormal accumulation of complex sugars in their cells, which affects many of …
MPS I - National MPS Society
MPS I (Hurler-Scheie) is a continuum of severity based upon the symptoms, ranging from severe to attenuated. There is a great deal of variability of symptoms among individuals with MPS I, often making the specific designation difficult.